文献速递病毒性肝炎结核与非结核分枝杆菌

结核合并乙肝抗病毒治疗可预防肝损伤

Antiviral Therapy for Hepatitis B Prevents Liver Injury in Patients With Tuberculosis and Hepatitis B Coinfection.
PubMed 文献 · Clin Infect Dis · 2020-01-01

该研究基于香港公立医院16年数据,纳入3698例结核-乙肝共感染患者,采用倾向评分校正的Cox回归分析。

要点

  • 结核诊断时启动乙肝抗病毒治疗可降低药物性肝损伤住院风险
  • 延迟至1年内启动抗病毒者肝损伤住院及肝相关死亡风险仍较高

核心结论

  • 结核诊断时给予乙肝抗病毒治疗可降低结核-乙肝共感染患者的肝损伤风险。

研究设计与样本

  • 人群层面回顾性队列研究,纳入香港公立医院16年间治疗的3698例结核-乙肝共感染患者;采用倾向评分校正的多变量Cox比例风险模型分析。

主要发现

  • 3698例中488例(13.2%)在结核诊断时接受抗病毒治疗;其余3210例中446例(13.9%)在1年内启动抗病毒治疗。
  • 与1年内启动抗病毒者相比,诊断时即抗病毒者肝损伤住院风险及肝相关死亡风险均更低。

临床怎么用

  • 对结核-乙肝共感染患者,考虑在结核诊断时即启动乙肝抗病毒治疗以降低肝损伤风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic hepatitis B virus (HBV) infection increases the risk of liver injury in patients who undergo antituberculosis treatment. It is uncertain whether antiviral treatment for HBV at the time of tuberculosis diagnosis would reduce the risk of liver injury. METHODS: We performed a population-level, retrospective, cohort study that involved all patients with tuberculosis-HBV coinfection treated in public hospitals in Hong Kong over a 16-year period. Patients who received antiviral treatment at the time of tuberculosis diagnosis were considered "patients on antiviral therapy." A multivariable Cox proportional hazards model was used to determine the adjusted hazard ratio of hospitalization due to drug-induced liver injury within 1 year in patients on antiviral therapy, adjusting for the propensity score. RESULTS: Of 3698 patients with tuberculosis-HBV coinfection, 488 (13.2%) were patients on antiviral therapy. Of the remaining 3210 patients, 446 (13.9%) started antiviral therapy within 1 year of tuberculosis diagnosis. Adjusting for the propensity score, patients on antiviral therapy had a lower risk of hospitalization due to drug-induced liver injury compared with those not on treatment (adjusted hazard ratio, 0.44; 95% confidence interval .26-.72). Compared with patients who started antiviral therapy within 1 year of tuberculosis diagnosis, patients on antiviral therapy also had a lower risk of hospitalization due to drug-induced liver injury and a lower risk of liver-related mortality. CONCLUSIONS: We show that antiviral treatment for HBV given at the time of tuberculosis diagnosis reduced the risk of liver injury in tuberculosis-HBV coinfected patients.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Lui GCY, Wong NS, Wong RYK, et al. Antiviral Therapy for Hepatitis B Prevents Liver Injury in Patients With Tuberculosis and Hepatitis B Coinfection. Clin Infect Dis. 2020. PMID: 30919884. doi:10.1093/cid/ciz241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。